HTTIF (HighTide Therapeutics) Other Gross PPE: $0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HTTIF HighTide Therapeutics Inc HTTIF
9 GF Score
Price $0.39
! 3 Warning Signs
View Full Analysis

What is HighTide Therapeutics Other Gross PPE?

HighTide Therapeutics HTTIF 9 Other Gross PPE is $0.00 Mil as of Jun. 2026. GuruFocus rates HTTIF with a GF Score™ of 9/100. The stock has 3 warning signs investors should review.

HighTide Therapeutics's Other Gross PPE for the quarter that ended in Jun. 2026 was $0.00 Mil.

HighTide Therapeutics's quarterly Other Gross PPE increased from Jun. 2025 ($0.00 Mil) to Dec. 2025 ($3.19 Mil) but then declined from Dec. 2025 ($3.19 Mil) to Jun. 2026 ($0.00 Mil).

HighTide Therapeutics's annual Other Gross PPE increased from Dec. 2023 ($1.97 Mil) to Dec. 2024 ($3.29 Mil) but then declined from Dec. 2024 ($3.29 Mil) to Dec. 2025 ($2.74 Mil).

HighTide Therapeutics Other Gross PPE Historical Data

* Premium members only.

The historical data trend for HighTide Therapeutics's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HighTide Therapeutics Other Gross PPE Chart

HighTide Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Gross PPE
0.21 0.42 1.97 3.29 2.74

HighTide Therapeutics Semi-Annual Data
Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Gross PPE Get a 7-Day Free Trial Premium Member Only 0.00 3.78 0.00 3.19 0.00
HTTIF
9GF Score
HighTide Therapeutics Inc HTTIF
Other Gross PPE is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HighTide Therapeutics Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Frequently Asked Questions Learn more about Other Gross PPE →
What does a Other Gross PPE of $0.00 Mil mean?
HighTide Therapeutics (HTTIF) has a Other Gross PPE of $0.00 Mil as of Jun. 2026. Other Gross PPE is property, plant and equipment recorded on a company's balance sheet that not otherwise classified. View historical data on HighTide Therapeutics and its competitors.
Is HighTide Therapeutics' Other Gross PPE too high?
HighTide Therapeutics' current Other Gross PPE is $0.00 Mil. Overall, HighTide Therapeutics has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does HighTide Therapeutics' Other Gross PPE compare to VRTX and REGN?
HighTide Therapeutics' Other Gross PPE of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Gross PPE for a Biotechnology company?
A good Other Gross PPE depends on the Biotechnology industry context. However, Other Gross PPE should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Gross PPE mean?
A high Other Gross PPE can signal that a stock is expensive relative to its fundamentals. Other Gross PPE is property, plant and equipment recorded on a company's balance sheet that not otherwise classified. View historical data on HighTide Therapeutics and its competitors. HighTide Therapeutics's current Other Gross PPE is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HighTide Therapeutics stock overvalued right now?
HighTide Therapeutics (HTTIF) has a current Other Gross PPE of $0.00 Mil. The current Other Gross PPE is $0.00 Mil. HighTide Therapeutics' overall GF Score™ is 9/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Gross PPE calculated?
Other Gross PPE is calculated from a company's financial statements. For HighTide Therapeutics (HTTIF), the current Other Gross PPE is $0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HighTide Therapeutics Business Description

Other Exchanges 02511:Hong Kong
Address Fubao Street, 9th to 10th Floor, Building D, Shenfang Park, Futian District, Shenzhen-Hong Kong Science and, Technology Innovation Cooperation Zone, Guangdong, Shenzhen, CHN, 518112
HighTide Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of first-in-class multifunctional, multi-targeted therapies for cardiovascular-kidney-metabolic (CKM) diseases and related metabolic disorders. The company is developing a pipeline of proprietary drug candidates targeting indications including type 2 diabetes mellitus, chronic kidney disease, obesity, metabolic dysfunction-associated steatohepatitis (MASH), and primary sclerosing cholangitis (PSC). Its core product candidate, HTD1801 (berberine ursodeoxycholate), is an orally delivered first-in-class anti-inflammatory metabolic modulator designed to target dual pathways involving AMPK activation and NLRP3 inflammasome inhibition.
9GF Score

Get the complete analysis for HTTIF

Other Gross PPE is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.39
Price